Artificial intelligence (AI) and machine learning (ML) are revolutionizing precision oncology by transforming how cancer is detected, diagnosed, and treated. These technologies analyze vast amounts of genomic, clinical, and imaging data to uncover hidden patterns that guide personalized treatment strategies. AI-driven tools are enhancing tumor classification, predicting drug responses, and optimizing clinical decision-making with unprecedented accuracy. Machine learning algorithms also accelerates drug discovery and biomarker identification, helping researchers design therapies tailored to each patient’s unique cancer profile.
At the Cancer Research and Development Conference 2026, this session will spotlight how AI and ML are advancing precision oncology from research to clinical application. Experts will discuss innovations in predictive modeling, data integration, and ethical considerations surrounding algorithmic medicine. Join us as we explore how intelligent technologies are reshaping the future of cancer care, making it more predictive, personalized, and precise than ever before.